Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinson's disease

被引:0
|
作者
Barone, P.
Poewe, W.
Tolosa, E.
Rascol, O.
Massey, D.
Debieuvre, C.
Albrecht, S.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S347 / S347
页数:1
相关论文
共 50 条
  • [21] Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease
    Mizuno, Y
    Yanagisawa, N
    Kuno, S
    Yamamoto, M
    Hasegawa, K
    Origasa, H
    Kowa, H
    MOVEMENT DISORDERS, 2003, 18 (10) : 1149 - 1156
  • [22] A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial of Paroxetine and Venlafaxine Extended Release for Depression in Parkinson's Disease
    Richard, I. H.
    McDermott, M.
    McDonald, W. M.
    MOVEMENT DISORDERS, 2010, 25 : S680 - S680
  • [23] Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Nomoto, Masahiro
    Mizuno, Yoshikuni
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    JOURNAL OF NEUROLOGY, 2014, 261 (10) : 1887 - 1893
  • [24] Rivastigmine in dementia associated with Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Emre, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 298 - 298
  • [25] Mucuna pruriens in parkinson's disease: a double-blind, randomized, placebo-controlled, crossover study
    Cilia, R.
    Laguna, J.
    Cassani, E.
    Cereda, E.
    Pezzoli, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E262 - E263
  • [26] Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
    Masahiro Nomoto
    Yoshikuni Mizuno
    Tomoyoshi Kondo
    Kazuko Hasegawa
    Miho Murata
    Masahiro Takeuchi
    Junji Ikeda
    Takayuki Tomida
    Nobutaka Hattori
    Journal of Neurology, 2014, 261 : 1887 - 1893
  • [27] A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease
    Payne, Thomas
    Appleby, Matthew
    Buckley, Ellen
    van Gelder, Linda M. A.
    Mullish, Benjamin H. H.
    Sassani, Matilde
    Dunning, Mark J. J.
    Hernandez, Dena
    Scholz, Sonja W. W.
    McNeill, Alisdair
    Libri, Vincenzo
    Moll, Sarah
    Marchesi, Julian R. R.
    Taylor, Rosie
    Su, Li
    Mazza, Claudia
    Jenkins, Thomas M. M.
    Foltynie, Thomas
    Bandmann, Oliver
    MOVEMENT DISORDERS, 2023, 38 (08) : 1493 - 1502
  • [28] Donepezil treatment in Parkinson's disease with dementia: A double-blind, placebo-controlled crossover study
    Aarsland, D
    Larsen, JP
    Janvin, C
    Laake, K
    NEUROLOGY, 2001, 56 (08) : A128 - A128
  • [29] Helicobacter pylori eradication in Parkinson's disease: A double-blind randomized placebo-controlled study
    Tan, A. H.
    Lim, S. Y.
    Mahadeva, S.
    Loke, M. F.
    Vadivelu, J. S.
    Marras, C.
    Fox, H.
    Lang, A. E.
    MOVEMENT DISORDERS, 2020, 35 : S422 - S425
  • [30] Efficacy and tolerability of transdermal nicotine patches in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Vieregge, P
    Sieberer, M
    Jacobs, H
    Hagenah, J
    NEUROLOGY, 2000, 54 (07) : A278 - A278